PNC Financial Services Group
VTGN icon

PNC Financial Services Group’s VistaGen Therapeutics VTGN Stock Holding History

PNC Financial Services Group’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-233
Closed -$7K – 4119
2019
Q3 		$7K Hold
233
– – ﹤0.01% 3678
2019
Q2 		$5K Hold
233
– – ﹤0.01% 3750
2019
Q1 		$9K Hold
233
– – ﹤0.01% 3627
2018
Q4 		$11K Hold
233
– – ﹤0.01% 3526
2018
Q3 		$10K Sell
233
-34
-13% -$1.38K ﹤0.01% 3674
2018
Q2 		$11K Buy
+267
New +$9.28K ﹤0.01% 3665

Other funds holding VTGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

PNC Financial Services Group's VTGN Position: Q4 2019 in Review

PNC Financial Services Group sold out of VistaGen Therapeutics (VTGN) in Q4 2019, closing a stake of 233 shares — an estimated $7K sold.

PNC Financial Services Group first reported a position in VTGN in Q2 2018 and held it in 6 quarters. The position peaked at $11K in Q4 2018. 25 funds tracked by Wall St. Rank hold VTGN as of Q4 2019.

  • PNC Financial Services Group reported no remaining VistaGen Therapeutics position as of Q4 2019 after selling out during the quarter.
  • PNC Financial Services Group sold 233 VistaGen Therapeutics shares in Q4 2019, an estimated $7K.
  • PNC Financial Services Group first reported a position in VistaGen Therapeutics in Q2 2018 and held it in 6 quarters.
  • PNC Financial Services Group's VistaGen Therapeutics position peaked at $11K in Q4 2018.
  • 25 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q4 2019.

Based on PNC Financial Services Group's 13F filing for Q4 2019, filed 7 Feb 2020.